/

Empresas

Im

No verificado

Immunis, Inc.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

9 Comunicados de prensa

Ver todos los comunicados de prensa

31/10/2025

Immunis Publishes Research Showing Body Fat Loss and Reversal of Liver Steatosis and Fibrosis, While Increasing Lean Muscle Mass, in Aged Models

Fuente

Editor

1.00

0

14/08/2025

Immunis Named Among Top 25 Biotech & Life Sciences Companies for 2025 by The Healthcare Technology Report

Fuente

Editor

1.00

0

12/05/2025

Multimedia

Eventos

Industria

Oncología

Salud

Sanidad

Medicina - Varios

Farmacéutica

Biotecnología

Immunis Named a Semifinalist in the $101 Million XPRIZE Healthspan Competition

Fuente

Editor

1.00

0

04/03/2025

Immunis’ Treats its First Patients for Sarcopenic Obesity

Fuente

Editor

1.00

0

11/01/2025

Biotecnología

Salud

Biología

Farmacéutica

Medicina - Varios

Immunis Closes $25 Million Series A-1 Financing Round

Fuente

Editor

1.00

0

04/11/2024

Multimedia

Industria

Veterinaria

Ciencia

Animales

Medicina - Varios

Biotecnología

Salud

Ir de compras

Farmacéutica

Immunis Initiates Non-Terminal Preclinical Studies to Address Canine Muscle Atrophy

Fuente

Editor

1.00

0

10/09/2024

Multimedia

Industria

Biotecnología

Higiene alimentaria

Salud

Farmacéutica

Medicina - Varios

FDA Grants Clearance for Immunis’ Phase II Sarcopenic Obesity Trial

Fuente

Editor

1.00

0

25/07/2024

Immunis Partners with Springbok Analytics to Assess Clinical Efficacy of IMMUNA in Reversing Sarcopenia

Fuente

Editor

1.00

0

28/06/2024

Mercado laboral

Oncología

Salud

Sanidad

Medicina - Varios

Farmacéutica

Biotecnología

Immunis Appoints Dr. Christina Weng to its Advisory Board

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0